Physician profile
Boni May
NPI 1740847144
$21,719.50
in general payments reported to CMS, 2019-2025
29 companies · $8,008 in 2025
The $8,008 reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,270 · 2022: $2,991 · 2023: $3,580 · 2024: $5,871 · 2025: $8,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $3,816 · Consulting Fee: $870 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,903.38 |
| Travel and Lodging | $3,815.87 |
| Consulting Fee | $870.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $870.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $5,572.32 | 2022-2025 | Assure Wcd |
| Cvrx, INC. | $3,893.90 | 2021-2025 | Barostim Neo System |
| Boston Scientific Corporation | $2,648.16 | 2022-2025 | General - Therapies, General - Tachy, Watchman Flx |
| Atricure, INC. | $2,068.50 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Biosense Webster, INC. | $1,651.54 | 2024-2025 | Carto 3 |
| Medtronic, INC. | $881.84 | 2021-2025 | Linq II, Reveal Linq, Micra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $641.41 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $426.86 | 2021-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $423.84 | 2022-2025 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $372.52 | 2021-2025 | Lifevest |
| Biotronik INC. | $359.93 | 2022-2024 | Acticor 7 Vr-T Dx, Biomonitor, Renamic Neo |
| Novo Nordisk INC | $340.15 | 2023-2025 | Ozempic |
| Esperion Therapeutics, INC. | $325.90 | 2021 | |
| Amgen INC. | $266.46 | 2021-2025 | Repatha, Repatha |
| Cardiva Medical, INC. | $242.84 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $208.44 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Abbott Laboratories | $184.91 | 2022-2024 | Cardiomems |
| Stryker Corporation | $171.04 | 2025 | Flowtriever |
| Pfizer INC. | $169.11 | 2022-2025 | |
| Edwards Lifesciences Corporation | $153.53 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $148.33 | 2025 | Uptravi, Opsumit |
| Philips North America LLC | $123.35 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.24 | 2022-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $110.06 | 2022 | |
| Novartis Pharmaceuticals Corporation | $66.65 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $55.28 | 2025 | Wainua |
| Cordis US Corp. | $32.67 | 2024 | Mynx Venous Vcd |
| Vital Connect, INC | $31.56 | 2024 | Vitalpatch Rtm |
| Alnylam Pharmaceuticals INC. | $27.16 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boni May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.